Our study demonstrates that persistent and chronic ITP patients treated with TPO‐RA have a significantly transient increase in PLT counts about 1 week after mild COVID‐19 infection and fall back to baseline 2–3 weeks after infection. The gene discussed is TPO; the disease is infection.